The WHO has identified antimicrobial resistance as one of the greatest threats to global health, and the molecular mechanisms underpinning that threat are the genes on this page. Knowing which gene is responsible for resistance in a given isolate tells you not just which antibiotics are ineffective but why they are ineffective, what other resistance might co-exist, and what the infection control implications are for a patient carrying an organism with that gene.
How Resistance Genes Are Categorised
Antibiotic resistance genes are categorised primarily by the mechanism of resistance they confer:
Enzymatic inactivation: the resistance protein directly destroys or modifies the antibiotic. Beta-lactamase genes (bla genes) produce beta-lactamase enzymes that hydrolyse the beta-lactam ring, the core structure of all penicillins, cephalosporins, and carbapenems. Aminoglycoside-modifying enzyme genes (aac, aph, ant genes) produce enzymes that chemically modify aminoglycoside antibiotics, preventing binding to the ribosome.
Target modification: the resistance protein alters the antibiotic's target so it can no longer bind effectively. mecA in MRSA produces an alternative penicillin-binding protein (PBP2a) that has low affinity for all beta-lactams. vanA and vanB in VRE produce enzymes that modify the peptidoglycan precursor from D-Ala-D-Ala to D-Ala-D-Lac, to which vancomycin cannot bind.
Efflux pumps: resistance proteins actively pump the antibiotic out of the bacterial cell faster than it can accumulate to inhibitory concentrations. tet(A), tet(B), and other tet genes encode efflux pumps for tetracyclines. mexAB-oprM, mexCD-oprJ, and related genes in Pseudomonas aeruginosa encode multidrug efflux pumps affecting fluoroquinolones, beta-lactams, and many other drug classes.
Reduced permeability: loss or modification of outer membrane porins reduces antibiotic entry into gram-negative bacteria. OprD loss in Pseudomonas reduces carbapenem uptake. OmpK35/OmpK36 loss in Klebsiella increases carbapenem resistance in combination with other mechanisms.
The Beta-Lactamase Families: An Indispensable Guide
Beta-lactamases are the most clinically important resistance enzymes because they act against the most widely used class of antibiotics. They are classified by the Ambler molecular classification (A, B, C, D) based on their amino acid structure, and by the Bush-Jacoby-Medeiros functional classification based on their substrate profile.
Class A beta-lactamases include TEM, SHV, and CTX-M enzymes. TEM-1 is one of the most prevalent beta-lactamase genes in gram-negative bacteria worldwide, originally conferring ampicillin resistance. Extended-spectrum variants of TEM (TEM-3 through TEM-26 and beyond) and SHV (SHV-2 and beyond) can hydrolyse extended-spectrum cephalosporins. The CTX-M family, especially CTX-M-15 and CTX-M-14, has overtaken TEM and SHV as the dominant ESBL globally. CTX-M enzymes are particularly efficient at hydrolysing cefotaxime (hence CTX-M) and most other third-generation cephalosporins.
KPC (Klebsiella pneumoniae carbapenemase) is a Class A carbapenemase of exceptional clinical importance. KPC-producing Enterobacteriaceae (particularly Klebsiella pneumoniae) were responsible for devastating hospital outbreaks in the USA (New York City, 2001 onwards), Israel, Italy, Greece, and many other countries. KPC hydrolyses all beta-lactams including carbapenems and is often co-located on plasmids with resistance genes for multiple other antibiotic classes, leaving very few treatment options.
Class B metallo-beta-lactamases (MBLs) use a zinc ion in their active site to hydrolyse carbapenems. They are the only beta-lactamases that cannot be inhibited by standard beta-lactamase inhibitors (clavulanate, tazobactam, avibactam). NDM (New Delhi metallo-beta-lactamase, first described in New Delhi, 2008), VIM (Verona integron-encoded MBL), and IMP (imipenem-hydrolysing MBL) are the most clinically significant. NDM has spread globally with extraordinary speed through international travel and healthcare, and is now found on every continent.
Class C AmpC beta-lactamases are typically chromosomally encoded in many gram-negative species (Enterobacter, Serratia, Citrobacter, Morganella, Pseudomonas: the ESCPM or SPACE organisms). AmpC can be induced by beta-lactam exposure, which causes inactivation of treatment even if the organism tested susceptible on initial in vitro testing. Plasmid-borne AmpC genes (CMY, DHA, FOX) have spread to organisms that do not normally produce AmpC.
Class D OXA-type beta-lactamases: OXA-23, OXA-24, OXA-48, OXA-51 are the most important carbapenem-hydrolysing OXA enzymes. OXA-48 is a major cause of carbapenem resistance in Klebsiella pneumoniae and E. coli in Europe, the Middle East, and North Africa. Critically, OXA-48 hydrolyses carbapenems relatively slowly and may not produce high-level resistance on its own, meaning OXA-48-producing organisms may appear susceptible to carbapenems on standard disc diffusion while still carrying the gene.
mecA and MRSA: The Resistance That Changed Hospital Infection Control
mecA encodes PBP2a (also called PBP2'), an alternative penicillin-binding protein that is functional in cell wall synthesis but has very low affinity for all beta-lactam antibiotics. In a bacterium carrying mecA, beta-lactams bind to and inhibit the normal PBPs but cannot bind to PBP2a, which continues functioning as a substitute. Cell wall synthesis continues. The organism grows.
mecA is located on a mobile genetic element called the Staphylococcal Cassette Chromosome mec (SCCmec). SCCmec is a genomic island that integrates into the Staphylococcal chromosome near the origin of replication and is transferred between Staphylococcus species at low frequency. Different SCCmec types (I through XI described to date) have different sizes, gene content, and associated resistance genes. Community-associated MRSA strains (such as USA300, the dominant community MRSA clone in North America) typically carry the smaller SCCmec IV or V.
Detection of mecA: the cefoxitin disc diffusion test (zone diameter below 19 mm by EUCAST) is the standard phenotypic screen for mecA-mediated resistance and is more reliable than oxacillin or methicillin disc testing. Molecular confirmation by PCR targeting mecA (or mecC, the rare homologue detected in livestock-associated MRSA) is performed for screening purposes, research, and when phenotypic tests are ambiguous.
Plasmid-Mediated Horizontal Gene Transfer: Why Resistance Spreads So Fast
Many of the most clinically dangerous resistance genes are carried on plasmids: small, circular, self-replicating DNA molecules that are separate from the bacterial chromosome. Plasmids can be transferred between bacteria by conjugation (direct cell-to-cell contact through a mating pilus), by transduction (via bacteriophage), and by transformation (uptake of naked DNA from the environment).
A resistance plasmid may carry multiple resistance genes, sometimes covering 5 to 10 different antibiotic classes simultaneously. When a single plasmid carrying genes for resistance to carbapenems, aminoglycosides, fluoroquinolones, and tetracyclines transfers to a new bacterial species, that species becomes resistant to all those classes at once. This is why carbapenem-resistant organisms are often resistant to nearly every available antibiotic.
The clinical implication for infection control: detecting a carbapenemase gene in one organism in a ward should trigger enhanced screening for other colonised patients, because the plasmid may already have transferred to other species in the same environment.
How Laboratories Detect Resistance Genes
Conventional PCR: specific primers amplifying the target gene from bacterial DNA or directly from the clinical sample. Rapid, specific, but requires knowing which gene(s) to test for. Multiplex PCR panels test simultaneously for multiple resistance genes.
Real-time PCR (qPCR): provides quantitative results and faster turnaround (within 1 to 4 hours for rapid panels). The GeneXpert system (Cepheid) uses qPCR on a closed-cartridge system: MRSA, VRE, and carbapenemase genes can be detected directly from swabs or samples with results in 1 to 2 hours, without the need for culture first.
Whole Genome Sequencing (WGS): sequences the entire genome of the organism, allowing identification of all resistance genes, their molecular context (plasmid vs chromosomal), and the specific variant (for example, which CTX-M or which KPC). WGS is now used in reference laboratories for outbreak investigation, epidemiological surveillance, and investigation of complex resistance patterns. Turnaround time is 24 to 48 hours in modern laboratories using automated short-read sequencing platforms.
Frequently Asked Questions
What is a carbapenemase?
A carbapenemase is a beta-lactamase enzyme capable of hydrolysing carbapenem antibiotics (meropenem, imipenem, ertapenem). Carbapenems are often last-resort antibiotics for gram-negative infections, so carbapenemase production leaves very few treatment options. The most important clinical carbapenemases are KPC (Class A), NDM and VIM (Class B metallo-beta-lactamases), and OXA-48 (Class D).
What is mecA?
mecA is the gene encoding PBP2a (penicillin-binding protein 2a), an alternative penicillin-binding protein with very low affinity for all beta-lactam antibiotics. In Staphylococcus aureus, mecA confers resistance to all beta-lactams, defining MRSA. In coagulase-negative staphylococci, mecA similarly confers methicillin resistance.
What does ESBL stand for?
ESBL stands for Extended-Spectrum Beta-Lactamase. ESBLs are beta-lactamase enzymes that can hydrolyse and inactivate extended-spectrum cephalosporins (such as cefotaxime, ceftriaxone, ceftazidime) as well as penicillins. ESBL-producing organisms are not susceptible to most beta-lactam antibiotics but retain susceptibility to carbapenems (unless carbapenemase genes are also present). CTX-M enzymes are the dominant ESBL globally.
What is vancomycin resistance in Enterococcus?
Vancomycin-resistant Enterococcus (VRE) carries van gene clusters (vanA, vanB, vanC, and others). The vanA and vanB clusters encode enzymes that modify the terminal peptidoglycan precursor from D-Ala-D-Ala (which vancomycin binds) to D-Ala-D-Lac (to which vancomycin cannot bind). This single modification reduces vancomycin affinity a thousandfold. vanA confers high-level resistance to both vancomycin and teicoplanin; vanB confers variable resistance to vancomycin but retains teicoplanin susceptibility.
What is the difference between intrinsic and acquired resistance?
Intrinsic resistance is a property of the species as a whole, present in all strains without any resistance gene transfer needed. For example, all Pseudomonas aeruginosa have intrinsic resistance to ampicillin (due to chromosomal AmpC and low outer membrane permeability). Acquired resistance arises from gene mutations or acquisition of resistance genes from other organisms, and may be present in some strains of a species but not others. MRSA is acquired resistance; Pseudomonas ampicillin resistance is intrinsic.
What is horizontal gene transfer?
Horizontal gene transfer (HGT) is the movement of genetic material between bacteria by non-reproductive means: conjugation (plasmid transfer by direct contact), transduction (transfer via bacteriophage), and transformation (uptake of extracellular DNA). HGT allows resistance genes, particularly those on mobile genetic elements like plasmids and transposons, to spread between different bacterial species very rapidly, far faster than evolution alone would allow.
What is the MCR-1 gene?
MCR-1 (mobilised colistin resistance) is a plasmid-borne gene encoding a phosphoethanolamine transferase that modifies lipid A, reducing the binding affinity of colistin (polymyxin E) to the outer membrane. Colistin is one of the few antibiotics remaining active against some carbapenem-resistant gram-negative bacteria. MCR-1 (and its family members MCR-2 through MCR-9) transfers the resistance to colistin to previously susceptible organisms, further narrowing treatment options for pan-drug-resistant strains.
What is WGS in clinical microbiology?
Whole Genome Sequencing (WGS) determines the complete nucleotide sequence of an organism's genome. In clinical microbiology, WGS is used to identify all resistance genes and their genetic context, to determine the strain typing of outbreak isolates (replacing traditional methods like PFGE and MLST), to investigate transmission chains in hospitals and communities, and to detect virulence genes. Most clinical WGS uses short-read sequencing platforms (Illumina) with turnaround times of 24 to 48 hours.
What is an integron?
An integron is a genetic element that captures and expresses genes (particularly antibiotic resistance gene cassettes) through a site-specific recombination mechanism. Class 1 integrons are extremely common in gram-negative clinical isolates and can accumulate multiple resistance gene cassettes in a single structure. A single Class 1 integron can carry resistance genes for aminoglycosides, trimethoprim, chloramphenicol, and other drugs simultaneously. They are commonly found on conjugative plasmids, facilitating their spread.
What is OXA-48?
OXA-48 is a Class D (OXA-type) beta-lactamase that can hydrolyse carbapenems, particularly imipenem, with lower efficiency than KPC or MBL carbapenemases. OXA-48-producing Klebsiella pneumoniae and E. coli are common in the Middle East, North Africa, and increasingly in Europe. A clinically important challenge with OXA-48 is that isolates may appear susceptible or intermediate to carbapenems on standard susceptibility testing while carrying the gene, because the hydrolysis rate may be insufficient to raise the carbapenem MIC above the breakpoint without additional permeability changes.